Biotinylated Human IgG1 (L234A, L235A) Kappa Isotype Control (mAb, carrier free, MALS verified)

A hapten is a small molecule that can elicit an immune response only when conjugated with a large carrier such as a protein. Typical haptens include drugs, urushiol, quinone, steroids, etc. Peptides and non-protein antigens usually need conjugating to a carrier protein (such as BSA (bovine serum albumin) or KLH (keyhole limpet hemocyanin) to become good immunogens) . Additionally, haptens should be administered with an adjuvant to ensure a high quality immune response. It is important that the hapten design (preserving greatly the chemical structure and spatial conformation of target compound), selection of the appropriate carrier protein and the conjugation method are key conditions for the desired specificity anti-hapten antibodies. We design anti-hapten antibodies based on the HaptenDB information.

Product Specifications

Background

Host

HEK293

Origin Species

Human

Target

IgG control

Conjugation

Biotin-labeled

Tag

Human IgG1 (L234A, L235A) | Human Kappa

Stability

-20°C to -70°C for 12 months in lyophilized state; -70°C for 3 months under sterile conditions after reconstitution. For long term storage, the product should be stored at lyophilized state at -20°C or lower. Please avoid repeated freeze-thaw cycles.

Purity

0.9

Bioactivity

Immobilized DNP-Albumin Conjugate, Bovine at 10 μg/mL (100 μL/well) can bind Biotinylated Human IgG1 (L234A, L235A) Kappa Isotype Control (mAb) (Cat. No. DNP-BL1538) with a linear range of 0.6-20 ng/mL (QC tested).